Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia.
Head Neck., Dec;34(12):1681-703 (2012)
Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck.
PLoS ONE., 7(7):e42048 (2012)
Why are more costly and more dangerous surgical procedures being developed?more costly and dangerous surgical procedures.
Arch. Otolaryngol. Head Neck Surg., Jun;138(6):539-40 (2012)
Alcohol-related predictors of delirium after major head and neck cancer surgery.
Arch. Otolaryngol. Head Neck Surg., Mar;138(3):266-71 (2012)
Mucosal melanoma of the head and neck.
J Natl Compr Canc Netw., Mar;10(3):320-38 (2012)
The value of PET/CT to assess clinically negative necks.
Eur Arch Otorhinolaryngol., Nov;269(11):2411-4 (2012)
Gankyrin, a biomarker for epithelial carcinogenesis, is overexpressed in human oral cancer.
Anticancer Res., Sep;31(9):2683-92 (2011)
Head and neck cancers.
J Natl Compr Canc Netw., Jun;9(6):596-650 (2011)
When to manage level V in head and neck carcinoma?
Laryngoscope., Mar;121(3):545-7 (2011)
When to manage level V in head and neck carcinoma?
Laryngoscope., Jan (2011)
Significance of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: initial results.
Arch. Otolaryngol. Head Neck Surg., Dec;136(12):1274-9 (2010)
When to address level I lymph nodes in neck dissections?
Otolaryngol Head Neck Surg., Mar;142(3):355-8 (2010)
Maxillary removal and reinsertion: a favorable approach for extensive anterior cranial base tumors.
Otolaryngol Head Neck Surg., Mar;142(3):322-6 (2010)
Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial.
J. Clin. Oncol., Mar;28(8):1395-400 (2010)
Patterns of recurrence and survival of head and neck adenoid cystic carcinoma after definitive resection.
Laryngoscope., Jan;120(1):65-70 (2010)
Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup.
Arch. Otolaryngol. Head Neck Surg., Oct;135(10):1024-9 (2009)
Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C.
Head Neck., Nov;31(11):1393-422 (2009)
Factors affecting long-term survival in patients with recurrent head and neck cancer may help define the role of post-treatment surveillance.
Laryngoscope., Nov;119(11):2135-40 (2009)
Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instability.
PLoS ONE., 4(3):e4941 (2009)
Tonsillectomy vs. deep tonsil biopsies in detecting occult tonsil tumors.
Laryngoscope., Jan;119(1):102-6 (2009)
The impact of surgery in the management of the head and neck carcinoma involving the carotid artery.
Laryngoscope., Oct;118(10):1771-4 (2008)
Head and neck cancers.
J Natl Compr Canc Netw., Aug;6(7):646-95 (2008)
Molecular signatures of metastasis in head and neck cancer.
Head Neck., Oct;30(10):1273-83 (2008)
Esophageal reconstruction with larynx preservation using forearm-free flap.
Laryngoscope., Oct;118(10):1750-2 (2008)
Prolonged survival with continuous infusion topotecan: a report of 2 cases.
J. Pediatr. Hematol. Oncol., Jun;30(6):468-70 (2008)
Ten specialty boards report accomplishments and plans: part I.
Bull Am Coll Surg., Mar;89(3):24-32 (2004)
Transoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx: report of Southwest Oncology Group Phase 2 Trial S9709.
Arch. Otolaryngol. Head Neck Surg., Oct;133(10):1044-50 (2007)
Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Laryngoscope., Jul;117(7):1173-9 (2007)
Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN): a Southwest Oncology Group Phase II study.
Cancer Invest., 25(3):182-8 (2007 Apr-May)
Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
Cancer Res., May;67(10):4657-64 (2007)
Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience.
Arch. Otolaryngol. Head Neck Surg., Apr;133(4):320-6 (2007)
Angiolipoma of the neck.
Otolaryngol Head Neck Surg., Oct;135(4):643-4 (2006)
Research education and training in otolaryngology: meeting summary and research opportunities.
Otolaryngol Head Neck Surg., Sep;135(3):361-7 (2006)
Intensification regimen for advanced-stage resectable hypopharyngeal carcinoma.
Arch. Otolaryngol. Head Neck Surg., Apr;132(4):385-9 (2006)
Long-term results of a multimodal intensification regimen for previously untreated advanced resectable squamous cell cancer of the oral cavity, oropharynx, or hypopharynx.
Laryngoscope., Apr;116(4):607-12 (2006)
p16 gene alterations in locally advanced squamous cell carcinoma of the head and neck.
Oncol. Rep., Mar;15(3):661-5 (2006)
Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer.
Proc. Natl. Acad. Sci. U.S.A., Jan;103(4):982-7 (2006)
DNA copy number gains in head and neck squamous cell carcinoma.
Oncogene., Mar;25(9):1424-33 (2006)
Somatic acquisition and signaling of TGFBR1*6A in cancer.
JAMA., Oct;294(13):1634-46 (2005)
Intraoperative single fraction high-dose-rate brachytherapy for head and neck cancers.
Brachytherapy., 4(3):217-23 (2005)
Head and neck cancers.
J Natl Compr Canc Netw., May;3(3):316-91 (2005)
Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial.
J. Clin. Oncol., Jan;23(1):88-95 (2005)
Mohs micrographic surgery and the otolaryngologist.
Am J Otolaryngol., 25(6):385-93 (2004 Nov-Dec)
Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
Head Neck., Jul;26(7):561-72 (2004)
Role of the physician versus the patient in the detection of recurrent disease following treatment for head and neck cancer.
Laryngoscope., Feb;114(2):232-5 (2004)
Safety and efficacy of transcervical resection of parapharyngeal space neoplasms.
Ann. Otol. Rhinol. Laryngol., Dec;110(12):1093-8 (2001)
Intraoperative high dose rate brachytherapy can be used to salvage patients with previously irradiated head and neck recurrences.
Rev Med Univ Navarra., 43(2):56-61 (1999 Apr-Jun)
Somatic INK4a-ARF locus mutations: a significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck.
Mol. Carcinog., Jan;30(1):26-36 (2001)
Differential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neck.
Br. J. Cancer., Jan;84(2):237-43 (2001)
Head and neck squamous cell carcinoma: measurement of plasma parathyroid hormone-related protein and serum and urine calcium concentrations.
Otolaryngol Head Neck Surg., Nov;123(5):558-62 (2000)
Closed laryngectomy using the automatic linear stapling device.
Laryngoscope., Aug;110(8):1402-5 (2000)
Summary of the proceedings of the United States and Japan Head and Neck Cancer Clinical Trials Summit, 19-20 September 1997, Kyoto, Japan.
J. Cancer Res. Clin. Oncol., Jul;125(7):433-8 (1999)
Intraoperative electron beam radiotherapy for previously irradiated advanced head and neck malignancies.
Int. J. Radiat. Oncol. Biol. Phys., Dec;42(5):1085-9 (1998)
Tissue-conserving surgery for prognosis, treatment, and function preservation.
Laryngoscope., Nov;108(11 Pt 1):1599-604 (1998)
Frequent mutation of p16 in squamous cell carcinoma of the head and neck.
Laryngoscope., Jun;108(6):923-8 (1998)
Maxillary removal and reinsertion for anterior cranial base tumors: long-term results.
Arch. Otolaryngol. Head Neck Surg., Feb;124(2):149-52 (1998)
Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas of the head and neck.
Carcinogenesis., Nov;18(11):2285-90 (1997)
Update on intraoperative analysis of mandibular margins.
Am J Otolaryngol., 18(6):396-9 (1997 Nov-Dec)
Factors involved in long- and short-term mandibular plate exposure.
Arch. Otolaryngol. Head Neck Surg., Feb;123(2):217-22 (1997)
Intensified regimen for advanced head and neck squamous cell carcinomas.
Arch. Otolaryngol. Head Neck Surg., Feb;123(2):139-44 (1997)
One-stage reconstruction of partial laryngopharyngeal defects.
Laryngoscope., Feb;107(2):247-53 (1997)
Maxillary malignant mesenchymoma and massive fibrous dysplasia.
Arch. Otolaryngol. Head Neck Surg., Jan;123(1):106-9 (1997)
Mortality and morbidity with intraoperative radiotherapy for head and neck cancer.
Am J Otolaryngol., 17(5):308-10 (1996 Sep-Oct)
Determination of the efficacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinoma.
Laryngoscope., Aug;106(8):972-6 (1996)
Resection of the internal carotid artery and replacement with greater saphenous vein: a safe procedure for en bloc cancer resections with carotid involvement.
J. Vasc. Surg., May;23(5):775-80; discussion 781-2 (1996)
Pharmacodynamics of taxol in human head and neck tumors.
Cancer Res., May;56(9):2086-93 (1996)
Xenograft growth and histodifferentiation of squamous cell carcinomas of the pharynx and larynx.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod., Feb;81(2):197-202 (1996)
A functional status scale for measuring quality of life outcomes in head and neck cancer patients.
Cancer Nurs., Dec;18(6):452-7 (1995)
Preoperative identification of patients at risk for delirium after major head and neck cancer surgery.
Laryngoscope., Oct;105(10):1066-8 (1995)
Rapid analysis of mandibular margins.
Laryngoscope., May;105(5 Pt 1):475-7 (1995)
Adjunctive treatment of cranial base malignacies.
J Craniofac Surg., Jan;6(1):69-74 (1995)
The effect of perioperative blood transfusion on survival in head and neck cancer.
Arch. Otolaryngol. Head Neck Surg., Jul;120(7):711-6 (1994)
Chemotherapy as predictor of compliance.
J Surg Oncol., Mar;55(3):143-8 (1994)
Analysis of frequency of pulmonary atelectasis in patients undergoing pectoralis major musculocutaneous flap reconstruction.
Head Neck., 16(1):25-9 (1994 Jan-Feb)
Phase II study of edatrexate in advanced head and neck cancer. A Southwest Oncology Group study.
Invest New Drugs., 12(4):341-4 (1994)
Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck datab
Int. J. Radiat. Oncol. Biol. Phys., Dec;27(5):1011-6 (1993)